Moreover, recombinant multifunctional NAMPT (rCT-NAMPT) linked to the CT peptide that harbors the essential minimal residues required for binding CYBB and TLR4, may serve as a platform for developing safe and effective treatments of IBD. This evidence concerns the gene TLR4 and inflammatory bowel disease.